Healthcare >> CEO Interviews >> January 10, 2001

William Haseltine – Human Genome Sciences Inc (hgsi)

DR. WILLIAM A. HASELTINE is Chairman of the Board of Directors and Chief Executive Officer of Human Genome Sciences, Inc., (HGS), a company he founded in 1992. Human Genome Sciences' mission is to develop products to prevent, treat and cure disease based on its leadership in the discovery and understanding of human genes.William A. Haseltine holds a doctorate from Harvard University in Biophysics. Dr. Haseltine was a Professor at Dana-Farber Cancer Institute, Harvard Medical School and Harvard School of Public Health from 1976 to 1993. Dr. Haseltine became Chairman and CEO of HGS in 1993. He has a distinguished record of achievement in cancer and AIDS research and has received numerous awards for his scientific work. He is the founder and Editor of the journal, E- Biomed: The Journal of Regenerative Medicine. Dr. Haseltine is the Chairman of the Board of Trustees of the National Health Museum, a member of the Brookings Institution Board of Trustees as well as a trustee for the Committee for Economic Development. He has over 250 publications in scientific literature and has been awarded more than 50 patents for his discoveries. Dr. Haseltine also has many years of experience with biotechnology companies. Since 1981, he has founded seven companies, each in a different area of medicine. As a scientific advisor to HealthCare Ventures, he helped to establish an additional 20 biotechnology companies. Dr. Haseltine has received many honors for his achievements in science, medicine and business. Profile
TWST: Could you begin by giving a brief overview and history of Human

Genome Sciences?

Dr. Haseltine: Human Genome Sciences was formed in the summer of 1992,

and we opened our doors for